Soliton (NASDAQ:SOLY) Trading 2.7% Higher

Shares of Soliton Inc (NASDAQ:SOLY) traded up 2.7% during trading on Monday . The stock traded as high as $10.73 and last traded at $10.74, 7,721 shares were traded during trading. A decline of 99% from the average session volume of 846,240 shares. The stock had previously closed at $10.46.

The stock’s 50-day moving average price is $12.91.

A number of hedge funds have recently made changes to their positions in the stock. Tower Research Capital LLC TRC bought a new position in Soliton during the 2nd quarter valued at about $32,000. Bank of Montreal Can bought a new position in Soliton during the 2nd quarter valued at about $91,000. Royal Bank of Canada bought a new position in Soliton during the 2nd quarter valued at about $96,000. Morgan Stanley bought a new position in Soliton during the 2nd quarter valued at about $121,000. Finally, National Asset Management Inc. bought a new position in Soliton during the 1st quarter valued at about $162,000. 1.80% of the stock is currently owned by institutional investors.



Soliton Company Profile (NASDAQ:SOLY)

Soliton, Inc, an early stage medical device company, focuses on developing and commercializing products using a proprietary rapid acoustic pulse technology platform. It offers a device for the removal of tattoos. The company was founded in 2012 and is headquartered in Houston, Texas.

Read More: What is meant by holder of record?

Receive News & Ratings for Soliton Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Soliton and related companies with MarketBeat.com's FREE daily email newsletter.